Casdin Capital’s Sage Therapeutics SAGE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q3 | – | Sell |
-90,000
| Closed | -$4.23M | – | 40 |
|
|
2023
Q2 | $4.23M | Buy |
+90,000
| New | +$4.23M | 0.37% | 31 |
|
|
2020
Q2 | – | Sell |
-385,000
| Closed | -$11.1M | – | 44 |
|
|
2020
Q1 | $11.1M | Buy |
385,000
+155,000
| +67% | +$4.45M | 1.17% | 25 |
|
|
2019
Q4 | $16.6M | Sell |
230,000
-170,000
| -43% | -$12.3M | 1.53% | 21 |
|
|
2019
Q3 | $56.1M | Hold |
400,000
| – | – | 5.81% | 8 |
|
|
2019
Q2 | $73.2M | Hold |
400,000
| – | – | 6.85% | 5 |
|
|
2019
Q1 | $63.6M | Buy |
400,000
+88,000
| +28% | +$14M | 6.99% | 4 |
|
|
2018
Q4 | $29.9M | Hold |
312,000
| – | – | 5.11% | 8 |
|
|
2018
Q3 | $44.1M | Buy |
312,000
+62,000
| +25% | +$8.76M | 5.36% | 5 |
|
|
2018
Q2 | $39.1M | Hold |
250,000
| – | – | 5.47% | 4 |
|
|
2018
Q1 | $40.3M | Hold |
250,000
| – | – | 7.08% | 3 |
|
|
2017
Q4 | $41.2M | Buy |
250,000
+10,000
| +4% | +$1.65M | 10.03% | 1 |
|
|
2017
Q3 | $15M | Sell |
240,000
-15,000
| -6% | -$935K | 4.22% | 12 |
|
|
2017
Q2 | $20.3M | Hold |
255,000
| – | – | 7.51% | 2 |
|
|
2017
Q1 | $18.1M | Sell |
255,000
-4,500
| -2% | -$320K | 10.69% | 1 |
|
|
2016
Q4 | $13.3M | Sell |
259,500
-7,000
| -3% | -$357K | 10.94% | 1 |
|
|
2016
Q3 | $12.3M | Buy |
266,500
+38,000
| +17% | +$1.75M | 9.94% | 2 |
|
|
2016
Q2 | $6.89M | Buy |
228,500
+39,500
| +21% | +$1.19M | 6.85% | 7 |
|
|
2016
Q1 | $6.06M | Buy |
189,000
+45,989
| +32% | +$1.47M | 6.95% | 4 |
|
|
2015
Q4 | $8.34M | Buy |
+143,011
| New | +$8.34M | 7.37% | 2 |
|